lncRNA GPRC5D-AS1 as a ceRNA inhibits skeletal muscle aging by regulating miR-520d-5p

被引:0
|
作者
Yu, Miao [1 ]
He, Xiuting [1 ]
Liu, Ting [1 ]
Li, Jie [1 ]
机构
[1] First Hosp Jilin Univ, Dept Geriatr & Special Med Treatment, Changchun 130021, Peoples R China
来源
AGING-US | 2023年 / 15卷 / 23期
关键词
long non-coding RNA; miR-520d-5p; skeletal muscle aging; GPRC5D-AS1; competing endogenous RNA; LONG-NONCODING RNA; MYOD; DIFFERENTIATION; SARCOPENIA; SENESCENCE; CARCINOMA; ARREST; GROWTH; ROLES;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sarcopenia induced by muscle aging is associated with negative outcomes in a variety of diseases. Long non coding RNAs are a class of RNAs longer than 200 nucleotides with lower protein coding potential. An increasing number of studies have shown that lncRNAs play a vital role in skeletal muscle development. According to our previous research, lncRNA GPRC5D-AS1 is selected in the present study as the target gene to further study its effect on skeletal muscle aging in a dexamethasone-induced human muscle atrophy cell model. As a result, GPRC5D-AS1 functions as a ceRNA of miR-520d-5p to repress cell apoptosis and regulate the expression of muscle regulatory factors, including MyoD, MyoG, Mef2c and Myf5, thus accelerating myoblast proliferation and differentiation, facilitating development of skeletal muscle. In conclusion, lncRNA GPRC5D-AS1 could be a novel therapeutic target for treating sarcopenia.
引用
收藏
页码:13980 / 13997
页数:18
相关论文
共 50 条
  • [21] LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis
    Cui, Huaan
    Zhao, Jiang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (03) : 2284 - 2293
  • [22] LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis
    Lin, Jing
    Liao, Shasha
    Liu, Zewa
    Li, E.
    Wu, Xiaohua
    Zeng, Wanting
    CANCER BIOLOGY & THERAPY, 2021, 22 (03) : 257 - 266
  • [23] LncRNA-LINC00294 functions as a ceRNA in regulating JUP through competitively binding to miR-485-5p in breast cancer
    Yang, T.
    Yang, J.
    Zhou, H.
    Yang, Y-P.
    Han, S-S.
    Wang, T-R.
    Deng, Q.
    Ming, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S386 - S387
  • [24] LNCRNA LYPLA 1-2 INHIBITS GLIOMA DEVELOPMENT BY REGULATING THE MIR-217-5P/CCR7 AXIS
    Wang, Guanliang
    Xu, Zihui
    Un, Kailong
    Mu, Sen
    Pan, Yicheng
    Shan, Mengya
    Chen, Liusheng
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 137 - 141
  • [25] Circular RNA FNDC3B Protects Oral Squamous Cell Carcinoma Cells From Ferroptosis and Contributes to the Malignant Progression by Regulating miR-520d-5p/SLC7A11 Axis
    Yang, Jie
    Cao, Xing-Hua
    Luan, Ke-Feng
    Huang, Yun-Dong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] LncRNA PVT1 REGULATES GALLBLADDER CANCER PROGRESSION THROUGH miR-30d-5p
    Liu, K.
    Xu, Q.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (03): : 875 - 883
  • [27] LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1
    Wu, Zizheng
    Liu, Yinfeng
    Wei, Liguang
    Han, Meng
    JOURNAL OF SURGICAL RESEARCH, 2021, 257 : 501 - 510
  • [28] The lncRNA ADAMTS9-AS1/miR-185-5p/KAT7 ceRNA network inhibits cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy
    Song, Bangrong
    Li, Wei
    Xu, Xiaoyu
    Dang, Haiming
    Dong, Ran
    BIOMEDICAL RESEARCH-TOKYO, 2023, 44 (03): : 105 - 115
  • [29] The lncRNA UCA1 Enhances Pancreatic Cancer EMT by Regulating miR-708-5p and miR-135b-5p: A Bioinformatics Approach
    Askari, Nahid
    Pirouz, Marziye Shad
    Mafikandi, Vida
    Hadizadeh, Morteza
    Mousavi, Seyedeh Zahra
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (07) : 1659 - 1669
  • [30] LncRNA FAS-AS1 inhibits the progression of non-small cell lung cancer through regulating miR-19a-5p
    Yang, C-B
    Xiao, S-W
    Cheng, S-M
    Zhang, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (07) : 3775 - 3785